Olfr572 Inhibitors
Olfr572, a member of the extensive olfactory receptor gene family, plays a pivotal role in the intricate process of olfactory perception. As a G-protein-coupled receptor (GPCR), Olfr572 shares a common structural feature with neurotransmitter and hormone receptors, possessing a 7-transmembrane domain structure. This receptor is primarily involved in the recognition and transduction of odorant signals, initiating neuronal responses that ultimately lead to the perception of specific smells. The olfactory receptor gene family, to which Olfr572 belongs, constitutes the largest gene family in the genome. Notably, the nomenclature assigned to olfactory receptor genes and proteins for this organism is independent of other organisms, underscoring the unique and organism-specific nature of olfactory signaling.
Inhibition of Olfr572 involves the modulation of specific signaling pathways associated with its function. The diverse mechanisms of inhibition outlined in the table target pathways such as PI3 kinase signaling, MAPK/ERK pathway, calcium homeostasis, and cytoskeletal dynamics. By influencing these pathways, inhibitors indirectly impact cellular processes linked to Olfr572, shedding light on the intricate molecular and cellular mechanisms that govern olfactory signal transduction. These chemical tools provide valuable insights into the regulatory networks controlling the activity of Olfr572 and contribute to our understanding of the complex interplay of biochemical and cellular events underlying olfactory perception. The exploration of Olfr572 and its inhibition serves as a crucial avenue for unraveling the molecular intricacies of odorant recognition and the subsequent neuronal responses that define our sense of smell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A inhibits the activation of ADP-ribosylation factors (ARFs), disrupting vesicular transport from the endoplasmic reticulum (ER) to the Golgi apparatus. This impacts the intracellular trafficking pathways associated with Olfr572, indirectly affecting its function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3 kinase inhibitor that disrupts the PI3 kinase signaling pathway. By interfering with this pathway, it indirectly influences cellular processes related to Olfr572 function, offering insights into potential regulatory mechanisms associated with olfactory signal transduction. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine is a calcium channel blocker that affects calcium homeostasis. Its inhibitory action on calcium channels indirectly modulates cellular processes associated with Olfr572, providing a means to explore the impact of calcium signaling on olfactory receptor function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, disrupting the MAPK signaling pathway. By influencing this pathway, it indirectly affects cellular processes linked to Olfr572, offering a potential avenue for investigating the intricate molecular mechanisms governing olfactory signal transduction. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor that targets the MAPK/ERK pathway. Its inhibitory effect on this pathway indirectly influences processes associated with Olfr572, unraveling the complexity of intracellular signaling cascades involved in olfactory receptor function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3 kinase inhibitor disrupting PI3 kinase signaling. Its action on this pathway indirectly modulates cellular processes related to Olfr572 function, providing a valuable tool for probing the regulatory mechanisms governing olfactory signal transduction. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 inhibits CaMK signaling by targeting CaMKII. Its impact on this pathway indirectly influences cellular processes associated with Olfr572, shedding light on the role of CaMK signaling in the regulation of olfactory receptor function. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
Mitoxantrone affects topoisomerase II activity, disrupting DNA processes. Its impact on cellular DNA processes indirectly influences Olfr572-related pathways, offering insights into potential connections between DNA dynamics and olfactory receptor function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor affecting the MAPK/ERK pathway. Its inhibitory action on this pathway indirectly modulates cellular processes associated with Olfr572, providing a valuable tool for unraveling the intricate signaling networks governing olfactory signal transduction. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil is a calcium channel blocker affecting calcium homeostasis. Its inhibitory action on calcium channels indirectly influences cellular processes linked to Olfr572, offering a means to explore the role of calcium signaling in the regulation of olfactory receptor function. | ||||||